General Information
Product name
Company
Subspeciality
Modality
Disease targeted
Main task
Not specified
Technical Specifications
Population
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Regulatory Information
Pathway:
MDR
Class:
Class IIa
Pathway:
510(k) cleared
Class:
Class II
Other certifications
Not specified
Market Presence
On market since
AI Platforms
Resellers
Countries present
Paying clinical customers
Research/test users
Pricing Information
Pricing model
Based on
Evidence & Research
Peer-Reviewed Papers
View
Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI
Technical Papers
View
Leveraging 3d information in unsupervised brain mri segmentation
View
Use of PIXYL software analysis of brain MRI (with & without contrast) as valuable metric in clinical trial tracking in study of multiple sclerosis (MS) and related neurodegenerative processes
View
Use of Software Analytics of Brain MRI (with & without contrast) As Objective Metric in Neurological Disorders and Degenerative Diseases
Source: vendor | First published: Apr 11, 2024 | Last updated: Jul 9, 2025